Shaped primarily by discussions with Gen Xers and older millennials, a new campaign from a coalition formed by the CDC Foundation is using a familiar aesthetic to educate adults about managing high blood pressure. More: ‘Hypertension Bites’: AZ-backed coalition launches
read moreThe company is confident that results from a head-to-head trial against Regeneron’s Eylea could make Axpaxli “one of the most consequential advances in retina,” CEO Pravin Dugel, M.D., said in a statement. Investors were unimpressed, sending the biotech’s shares down
read more
Collaboration aims to speed access to challenging targets through an AI‑guided workflow More: Nuclera and leadXpro partner to accelerate structure‑based drug design Source: News
read moreSix years after the FDA approved Eli Lilly’s Retevmo to treat lung and thyroid cancers with a rare biomarker, the Indianapolis drugmaker is laying groundwork to move the treatment into the adjuvant setting, reporting the success of a phase 3
read more
Bocunebart shows significant reduction in monthly migraine days in patients with previous treatment failures More: Lundbeck reports positive phase 2b results for migraine prevention drug Source: News
read moreDetermined to avoid a repeat of the supply shortfalls that plagued early GLP-1 rollouts for obesity, Eli Lilly has amassed a sizable store of its oral weight loss candidate orforglipron. Specifically, Lilly had secured “pre-launch inventories” worth $1.5 billion as
read more© 1994 - 2026 B.M. Pharmaceuticals